Statin Drugs Support Immunotherapy for Mesothelioma, New Study Finds
There’s more evidence that statin drugs may improve the effectiveness of mesothelioma immunotherapy. The new study, led by Korean biochemists, is not the first to show that these anti-cholesterol medications may help mesothelioma patients. But this one goes a step further to explain why they help. Researchers focused on the impact of statin drugs on PD-1 expression. PD-1 is a protein that protects mesothelioma cells against immune system attack. The findings suggest that, by lowering PD-1 levels, anti-cholesterol drugs may play a greater role in the future of mesothelioma treatment. PD-1 and Mesothelioma Immunotherapy PD-1 is an immune checkpoint protein that occurs on the surface of cells. Normally, it helps keep the immune system from attacking healthy tissues. But mesothelioma…